C-终端激酶域结合和抑制动机阻止了FGFR2的构成性激活
Daniel Zingg1,2,3, Chi-Chuan Lin4, Julia Yemelyanenko1,2
1Division of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, the Netherlands.
Cancer research
|June 24, 2025
概括
切断FGFR2基因 (FGFR2ΔE18) 通过去除其C端尾部,驱动癌症. 这条尾巴中新发现的一种基因抑制了FGFR2的活性,防止了瘤原体的激活.
科学领域:
- 瘤致癌信号通路的使用.
- 癌症发展的分子机制
- 受体氨酸激酶生物学的生物学
背景情况:
- 受体氨酸激酶基因中的遗传变化是癌症的关键驱动因素.
- FGFR2基因切断,特别是18号外子 (E18) 缺失 (FGFR2ΔE18),是强大的致癌驱动因素.
- 这些变体往往缺乏C端尾部,但瘤发生的机制仍然不清楚.
研究的目的:
- 阐明C端尾损失激活FGFR2瘤发生的机制.
- 为了确定FGFR2 C终端内负责抑制激酶活性的功能性动机.
主要方法:
- 对Fgfr2-E18变体的汇编进行分析.
- 功能性注释和C端FGFR图案的排列.
- 改性FGFR2变异的瘤性和瘤性能力的评估.
主要成果:
- 之前注释的C-终端基因不能解释FGFR2ΔE18的瘤性.
- 发现了一种新型的C端氨酸-氨酸基因,它结合了激酶域.
- 这种基因抑制了FGFR2激酶的活性;它的变异复制了FGFR2ΔE18的瘤发生.
结论:
- FGFR2的C端尾包含一个关键动机,抑制其酶活性.
- 由于C端切断,这种动机的丧失导致异常的FGFR2激活和瘤发生.
- 了解这种机制可以了解FGFR2驱动的癌症.
更多相关视频
09:40Analysis of the c-KIT Ligand Promoter Using Chromatin Immunoprecipitation
Published on: June 27, 2017
7.8K
10:33Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors
Published on: October 26, 2015
11.4K
相关概念视频
Amplifying Signals via Enzymatic Cascade
9.7K
When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze...
9.7K
TGF - β Signaling Pathway
7.7K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.7K
MAPK Signaling Cascades
6.2K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
6.2K
Receptor Tyrosine Kinases
14.4K
Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...
14.4K
The JAK-STAT Signaling Pathway
9.3K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
9.3K
Calmodulin-dependent Signaling
5.3K
Calmodulin (CaM) is a calcium-binding protein in eukaryotes that controls various calcium-regulated cellular processes. It has four calcium-binding sites that bind calcium to form the calcium-calmodulin ( Ca2+-CaM) complex. GPCR stimulation increases the calcium levels in the cells that bind to CaM and induces a conformational change.
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
5.3K
